This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Jan 1;30(1):1.

doi: 10.1089/scd.2020.29007.laz.

Lazo Response to Weiss et al. (Re: DOI: 10.1089/scd.2020.0114)

Angel Lazo , Jr¹

Affiliations

PMID: 33404357
DOI: 10.1089/scd.2020.29007.laz

Comment

Lazo Response to Weiss et al. (Re: DOI: 10.1089/scd.2020.0114)

Angel Lazo , Jr. Stem Cells Dev. 2021.

. 2021 Jan 1;30(1):1.

doi: 10.1089/scd.2020.29007.laz.

Author

Angel Lazo , Jr¹

Affiliation

¹ Department of Internal Medicine, Englewood Hospital, Englewood, New Jersey, USA.

PMID: 33404357
DOI: 10.1089/scd.2020.29007.laz

No abstract available

PubMed Disclaimer

Comment on

Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.
Sengupta V, Sengupta S, Lazo A, Woods P, Nolan A, Bremer N. Sengupta V, et al. Stem Cells Dev. 2020 Jun 15;29(12):747-754. doi: 10.1089/scd.2020.0080. Epub 2020 May 12. Stem Cells Dev. 2020. PMID: 32380908 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- scite Smart Citations